Process View
Any process that activates or increases the frequency, rate, or extent of an adaptive immune response.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of adaptive immune response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| B2M | beta-2-microglobulin | 0.921 | Mouse | |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.881 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.875 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.845 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.838 | Human | |
| TRAF3 | TNF receptor-associated factor 3 | 0.798 | Human | |
| TRAF6 | TNF receptor-associated factor 6 | 0.748 | ||
| SYK | spleen tyrosine kinase | 0.745 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.740 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.697 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.689 | Human | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.663 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.607 | Human | |
| HLA-C | major histocompatibility complex, class I, C | 0.595 | Human | |
| HLA-E | major histocompatibility complex, class I, E | 0.568 | Human | |
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.549 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.548 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.538 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.534 | ||
| IL4R | interleukin 4 receptor | 0.531 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.519 | ||
| TAPBP | TAP binding protein (tapasin) | 0.457 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.395 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.372 | Mouse Rat | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.332 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.309 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.262 | Human | |
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.260 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.225 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.163 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.149 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.146 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.127 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.125 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.120 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.106 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.105 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.102 | ||
| TNF | tumor necrosis factor | 0.099 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.093 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.093 | ||
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.091 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.090 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.088 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.086 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.084 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.083 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.073 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.073 | ||
| CREBBP | CREB binding protein | 0.069 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.068 | Mouse | |
| TRADD | TNFRSF1A-associated via death domain | 0.067 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.061 | ||
| IDE | insulin-degrading enzyme | 0.055 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.054 | Human | |
| CSF1R | colony stimulating factor 1 receptor | 0.054 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.053 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.053 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.052 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.051 | ||
| CD80 | CD80 molecule | 0.051 | ||
| CFH | complement factor H | 0.049 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.048 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.046 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.046 | ||
| HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.044 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.044 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.044 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.044 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.041 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.041 | Human | |
| CD86 | CD86 molecule | 0.040 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.040 | ||
| IFNG | interferon, gamma | 0.040 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.039 | ||
| H2AFX | H2A histone family, member X | 0.037 | ||
| TANK | TRAF family member-associated NFKB activator | 0.037 | ||
| IL2RB | interleukin 2 receptor, beta | 0.036 | ||
| PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.036 | ||
| AR | androgen receptor | 0.035 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.035 | ||
| PVRL4 | poliovirus receptor-related 4 | 0.032 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.032 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.031 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.031 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.031 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.030 | ||
| IL7R | interleukin 7 receptor | 0.028 | ||
| IRF4 | interferon regulatory factor 4 | 0.027 | ||
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.026 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.026 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.026 | ||
| SQSTM1 | sequestosome 1 | 0.026 | ||
| IL10 | interleukin 10 | 0.023 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.023 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.023 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.023 | Human | |
| ENG | endoglin | 0.023 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.023 | ||
| IL4 | interleukin 4 | 0.022 | Mouse | |
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.022 | Mouse | |
| CD2 | CD2 molecule | 0.022 | ||
| PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.022 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.021 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.021 | Human Mouse | |
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.020 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.020 | ||
| CD48 | CD48 molecule | 0.020 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.020 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.019 | Human | |
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.019 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.019 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.019 | ||
| MEFV | Mediterranean fever | 0.019 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.019 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.019 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.019 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.018 | Human | |
| PLEK | pleckstrin | 0.018 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.018 | ||
| CTSS | cathepsin S | 0.018 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.018 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.018 | ||
| SMAD2 | SMAD family member 2 | 0.017 | ||
| FSTL1 | follistatin-like 1 | 0.017 | ||
| NUMBL | numb homolog (Drosophila)-like | 0.017 | ||
| FHL2 | four and a half LIM domains 2 | 0.017 | ||
| SH2D1A | SH2 domain containing 1A | 0.017 | ||
| STX6 | syntaxin 6 | 0.017 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.017 | ||
| TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.016 | ||
| TYROBP | TYRO protein tyrosine kinase binding protein | 0.016 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.016 | ||
| UBD | ubiquitin D | 0.016 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.016 | ||
| CD1C | CD1c molecule | 0.016 | ||
| IL21R | interleukin 21 receptor | 0.015 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.015 | ||
| CD163 | CD163 molecule | 0.015 | ||
| ITK | IL2-inducible T-cell kinase | 0.015 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.014 | Human | |
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.014 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.014 | ||
| BLNK | B-cell linker | 0.014 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.013 | Human | |
| KAT2B | K(lysine) acetyltransferase 2B | 0.013 | ||
| SNX3 | sorting nexin 3 | 0.013 | ||
| PPID | peptidylprolyl isomerase D | 0.013 | ||
| FOXO3 | forkhead box O3 | 0.013 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.012 | ||
| NSF | N-ethylmaleimide-sensitive factor | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.012 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.012 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.012 | Human | |
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.012 | ||
| FGL2 | fibrinogen-like 2 | 0.012 | ||
| HCP5 | HLA complex P5 | 0.012 | ||
| CD83 | CD83 molecule | 0.012 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.012 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.012 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.012 | ||
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.012 | Human | |
| SH2D2A | SH2 domain containing 2A | 0.012 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.011 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.011 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.011 | ||
| SMAD7 | SMAD family member 7 | 0.011 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.011 | Human | |
| SELL | selectin L | 0.011 | ||
| IRF1 | interferon regulatory factor 1 | 0.011 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.011 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.011 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.011 | Mouse | |
| CD84 | CD84 molecule | 0.011 | ||
| CD40LG | CD40 ligand | 0.011 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.011 | ||
| CFI | complement factor I | 0.011 | ||
| IL8 | interleukin 8 | 0.010 | ||
| TRAF3IP1 | TNF receptor-associated factor 3 interacting protein 1 | 0.010 | ||
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.010 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.010 |